Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study

Diabetes, Obesity and Metabolism

Volumn 19, Issue 11, 2017, Pages 1579-1586

  Connelly, Paul J ^a   Lonergan, Mike ^a   Soto Pedre, Enrique ^a   Donnelly, Louise ^a   Zhou, Kaixin ^a   Pearson, Ewan R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

acute kidney injury; database research; lactic acidosis; metformin; type 2 diabetes

Indexed keywords

LACTIC ACID; METFORMIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HIGH RISK PATIENT; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; BLOOD; CHEMICALLY INDUCED; DIABETIC NEPHROPATHY; INCIDENCE; MIDDLE AGED; VERY ELDERLY;

ACIDOSIS, LACTIC; ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INCIDENCE; LACTIC ACID; MALE; METFORMIN; MIDDLE AGED;

EID: 85021838744     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12978     Document Type: Article

References (32)

1. UK Prospective Diabetes Study Group (34). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. BMJ. 1998;352(UKPDS 34):703-713.
2. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 1997;103(6):491-497.
3. Brown JB, Pedula K, Barzilay J, Herson MK, Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care. 1998;21(10):1659-1663.
4. Duong JK, Furlong TJ, Roberts DM, et al. The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf. 2013;36:733-746.
5. Silvestre J, Carvalho S, Mendes V, et al. Metformin-induced lactic acidosis: a case series. J Med Case Rep. 2007;1:126.
6. Inzucchi S, Lipska K, Mayo M, Bailey C, McGuire D. Metformin in patients with type 2 diabetes and kidney disease a systematic review. JAMA. 2014;312(24):2668-2675.
7. Salpeter SR, Greyber E, Pasternak G, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;1:CD002967.
8. Eppenga WL, Lalmohamed A, Geerts AF, et al. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care. 2014;37(8):2218-2224.
9. Richy FF, Sabidó-Espin M, Guedes S, Corvino F, Gottwald-Hostalek U. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study. Diabetes Care. 2014;37(8):2291-2295.
10. Ekström N, Schiöler L, Svensson AM, et al. Effectiveness and safety of metformin in 51675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2012;2(4):e001076.
11. Heaf J. Metformin in chronic kidney disease: time for a rethink. Perit Dial Int. 2014;34(4):353-357.
12. Hung SC, Chang YK, Liu JS, et al. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study. Lancet Diabetes Endocrinol. 2015;3(8):605-614.
13. Gjedde S, Christiansen A, Pedersen SB, Rungby J. Survival following a metformin overdose of 63 g: a case report. Pharmacol Toxicol. 2003;93(2):98-99.
14. Brady W, Cartert C. Metformin overdose. React Wkly. 1997;645(1):9.
15. Hussain MI, Hall BM, Depczynski B, Connor SJ. Acute renal failure and metformin-associated lactic acidosis following colonoscopy. Diabetes Res Clin Pract. 2014;105(1):e6-e8.
16. Vecchio S, Giampreti A, Petrolini VM, et al. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol. 2014;52(2):129-135.
17. Renda F, Mura P, Finco G, Ferrazin F, Pani L, Landoni G. Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci. 2013;17(suppl 1):45-49.
18. Morris A, Boyle D, McMahon A, Greene S, MacDonald T, Newton R. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997;350(9090):1505-1510.
19. Kellum J, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.
20. Bellomo R, Ronco C, Kellum J, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212.
21. Linder A, Fjell C, Levin A, Walley KR, Russell JA, Boyd JH. Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med. 2014;189(9):1075-1081.
22. Lewington A, Kanagasundaram S. Clinical Practice Guidelines: Acute Kidney Injury. UK Renal Association; Hampshire, UK; 2011.
23. Hox JJ, Roberts JK. Handbook for Advanced Multilevel Analysis. New York, NY: Routledge; 2011.
24. van Berlo-van de Laar IRF, Vermeij CG, Doorenbos CJ. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. J Clin Pharm Ther. 2011;36(3):376-382.
25. Kamber N, Davis W, Bruce DG, Davis TME. Metformin and lactic acidosis in an Australian community setting: the Fremantle diabetes study. Med J Aust. 2008;188:446-449.
26. Liu F, Lu JX, Tang JL, et al. Relationship of plasma creatinine and lactic acid in type 2 diabetic patients without renal dysfunction. Chin Med J. 2009;122:2547-2553.
27. Lepelley M, Giai J, Yahiaoui N, Chanoine S, Villier C. Lactic acidosis in diabetic population: is metformin implicated? Results of a matched case-control study performed on the type 2 diabetes population of Grenoble Hospital University. J Diabetes Res. 2016;2016:3545914.
28. Girman CJ, Kou TD, Brodovicz K, et al. Risk of acute renal failure in patients with Type 2 diabetes mellitus. Diabet Med. 2012;29(5):614-621.
29. Martin MJ, FitzSullivan E, Salim A, Berne TV, Towfigh S. Use of serum bicarbonate measurement in place of arterial base deficit in the surgical intensive care unit. Arch Surg. 2005;140:745-751.
30. FitzSullivan E, Salim A, Demetriades D, Asensio J, Martin MJ. Serum bicarbonate may replace the arterial base deficit in the trauma intensive care unit. Am J Surg. 2005;190:941-946.
31. Lalau JD, Race JM. Metformin and lactic acidosis in diabetic humans. Diabetes Obes Metab. 2000;2:131-137.
32. Kajbaf F, Lalau JD. The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database. Diabet Med. 2013;30:345-348.